Collegium Pharmaceutical Announces Management Participation in Investor Conferences.

Collegium Pharmaceutical announced that its management team will participate in the 2025 Wells Fargo Healthcare Conference, Morgan Stanley 23rd Annual Global Healthcare Conference, and H.C. Wainwright 27th Annual Global Investment Conference. A live webcast of the fireside chats will be available on the company's website.

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) has announced that its management team will participate in several high-profile investor conferences this September. The company will be present at the 2025 Wells Fargo Healthcare Conference, the Morgan Stanley 23rd Annual Global Healthcare Conference, and the H.C. Wainwright 27th Annual Global Investment Conference [1].

The 2025 Wells Fargo Healthcare Conference is scheduled for Thursday, September 4, 2025, in Boston, MA. The Morgan Stanley event will feature a fireside chat on Monday, September 8, 2025, at 2:35 p.m. ET in New York, NY. The H.C. Wainwright conference will host a fireside chat on Tuesday, September 9, 2025, at 10:30 a.m. ET in New York, NY [1].

Collegium Pharmaceutical is a leading biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has a strong portfolio of responsible pain management medications and a growing neuropsychiatry business, driven by its differentiated treatment for ADHD, Jornay PM® [1].

For investors who cannot attend these events in person, Collegium Pharmaceutical will provide live webcasts of the fireside chats. The live webcasts will be available via the Investors section of the company's website, with replays archived for 90 days following the presentations [1].

References:
[1] https://www.marketscreener.com/news/collegium-to-participate-in-upcoming-investor-conferences-ce7c50dfd18bf223